NEW YORK (GenomeWeb) – Mission Bio said today that it has received a grant for around $1 million from the National Human Genome Research Institute as part of the National Institutes of Health Small Business Innovation Research program. The grant will support the development of Tapestri, the firm's single-cell analysis platform, which can process up to 10,000 cells.
Mission Bio launched Tapestri in October, along with a targeted panel for acute myeloid leukemia.
"The single-cell sequencing capability developed through this grant addresses the role that genetic heterogeneity plays in the progression of acute myeloid leukemia, and will potentially lead to improved stratification and therapy selection for the disease," Mission Bio CSO Dennis Eastburn said in a statement.
The grant adds to $10 million the firm raised in a Series A round in October.